Healio: Changes in Devices, Procedures Major Driver of Improvement in TAVR Outcomes

Changes in devices and procedural care were the biggest factor in improvements in short-term outcomes for patients undergoing transcatheter aortic valve replacement, researchers reported at TCT 2022.

Changes in patient comorbidities, due to TAVR becoming more widely available to lower-risk patients over time, were a major factor in improvements in long-term mortality after TAVR, but changes in devices and procedural care were also a factor, according to an analysis of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies registry.

“We believe that our findings emphasize the importance of device iterations and non-device procedural factors to short-term mortality and complications of TAVR, and maybe have important implications for future device innovation, particularly as we move to the treatment of other forms of valvular heart disease,” Suzanne V. Arnold, MD, MHA, professor of medicine at the University of Missouri-Kansas City School of Medicine and clinical scholar at Saint Luke’s Mid-America Heart Institute, said at a press conference.

Arnold and colleagues analyzed 161,196 patients included in the TVT registry who underwent TAVR at 596 U.S. hospitals between 2011 and 2018 to determine the contribution of changes in patient risk and procedure improvements to improved TAVR outcomes over time.

Read the full Healio article: Changes in Devices, Procedures Major Driver of Improvement in TAVR Outcomes

Related Content

Sep. 20, 2022
TCTMD: Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances
As TAVI outcomes have improved over the years, different factors seem to be driving changes in short-term complications and mortality.
Nov. 9, 2021
tctMD: SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years
After 2 years, clinical outcomes were similar, hemodynamics favored TAVI, and paravalvular leak favored surgery.
Oct. 1, 2020
Healio: No difference in sustained health status improvements in TAVR vs. surgical AVR
Patients who had TAVR had similar health status after five years with those who had surgical AVR, according to a new study by Dr. Suzanne Arnold.